HemoSense Strengthens Worldwide INRatio System Distributor Network; Expands U.S. Distribution And Enters China

SAN JOSE, Calif.--(BUSINESS WIRE)--July 27, 2005--HemoSense, Inc. (AMEX:HEM) today announced it has signed non-exclusive distribution agreements with McKesson Corporation (NYSE:MCK), National Distribution & Contracting, Inc. (NDC), Laboratory Supply Company (LABSCO) and Health Biomedic Ltd. to market and distribute the INRatio(R) System, a handheld blood coagulation monitoring system for point-of-care or in-home testing use. These four leading supply partners broaden the Company's U.S. reach, add China as a new market, and bring to 22 the number of distributors offering the INRatio System to professional healthcare providers and home-use markets worldwide. Leading pharmaceutical distributor and healthcare services company McKesson Corporation, and NDC, the largest organization of independent medical, surgical, dental and laboratory National supply distributors, will market and distribute the INRatio System in the United States. LABSCO, the largest, privately held distributor of clinical laboratory products in the United States, will further HemoSense's regional distribution efforts in the Midwest and Southeast. Health Biomedic is a well established distribution company based in China and will be the first partner to distribute the INRatio System in China and Hong Kong.